Current Positions

Chairman, Dept. Urology, St Vincent’s Private Hospital and Clinic and HMO St Vincents Hospital

Clinical Director, Prostate Cancer Research, The Kinghorn Cancer Centre

Clinical Director, The Australian Prostate Cancer Research Centre – New South Wales

Director, St. Vincent’s Prostate Cancer Centre

Conjoint Associate Professor, Department of Surgery, University of New South Wales Australia

Clinical Associate Professor, Sydney Medical School, University of Sydney

Clinical Professor, School of Health Sciences, University of Tasmania

Conjoint Professor, School of Medicine, University of Western Sydney

Chairman, St Vincent's Multidisciplinary Oncolcogy Team


Tertiary Education

1978 MBBS (Hons) University of New South Wales Australia
1980 FRACS Part I
1980 VQE
1988 FRACS (Urology) Part II


Professor Stricker was awarded Australia’s 2 nd highest award ,  Officer of the Order of Australia  (AO) on the Australia Day 2015 Honours list for “ Distinguished service to medicine and medical research , as a leading urologist , a robotic surgery pioneer , a teacher and mentor , and as an advocate for prostate cancer awareness “.

Personal Statement

Professor Phillip Stricker, AO, is a urologist and one of the leading experts in the treatment of prostate cancer in Australasia. He is Chairman of the Department of Urology at St Vincent’s Campus, the Director of the St Vincent’s Prostate Cancer Centre and the Clinical Director of the Australian Prostate Cancer Research Centre – NSW. He is also a professor at the University of Western Sydney, the University of Tasmania and associate professor at the University of New South Wales, Sydney and the University of Sydney.

His clinical practice is dedicated to the treatment of prostate cancer. This includes initial therapy and all post treatment side effects including erectile dysfunction and incontinence. He has performed over 6,500 radical prostatectomies, the largest Australasian series, 2000 of which have been performed using the latest robotic surgery technology. He also has one of the largest experiences in high-dose rate brachytherapy, low-dose rate brachytherapy, active surveillance and transperineal biopsies in Australasia. He has been one of the Australian pioneers in multiparametric MRI and PSMA-PET scan imaging and focal therapy using irreversible electroporation. He also has a large experience in impotence and incontinence assessment, urodynamics and treatments including penile prosthesis, sling surgery and artificial urinary sphincter surgery

His area of research focuses on the quality of life in patients after treatment, perfecting surgical techniques, the introduction of less invasive surgical techniques and the use of medical imaging for the detection and evaluation of prostate cancer. He was the driving force in setting up St Vincent’s Prostate Cancer Clinical Database and Tissue Bank in conjunction with the Garvan Institute, which is currently housed at The Kinghorn Cancer Centre. These resources contain extensive clinical and pathological outcome data and have resulted in a comprehensive scientific and clinical resource that has been acknowledged both nationally and internationally. Prof Stricker is a Member of the Australian Cancer Network working party that developed guidelines for the Management of Localised & Advanced Prostate Cancer and PSA Testing. These have been published and are evidence-based publications supported by NH&MRC. He has authored over 160 peer reviewed publications and has collaborative research ties within Australia and overseas.

Current Major Grants

  1. 2016 – 2019: Ramsay Foundation – The MAGNIFI Trial. Stricker P. $814,000.00
  2. 2017 – 2018: Commonwealth Department of Health: Cancer Control – Australian Prostate Cancer Research Centres. Stricker P, Hayes V, Horvath L, Clarke S, Kench J, Joshua A, Rasiah K, Nguyen Q. $1.5million. 
  3. 2019 – 2023: Cancer Institute of NSW Programme Grant. $4million

Top Recent Publications

  1. Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development
    Cancer Epidemiol Biomarkers Prev 19: 2611-2622
    Bianco-Miotto T, Chiam K, Buchanan G, Jindal S, Day TK, Thomas M, Pickering MA, O ’Loughlin M, Ryan NK, Raymond WA, Horvath LG Kench JG, Stricker P, Marshall VR, Sutherland R L, Henshall SM, Gerald WL, Scher HI, Risbridger GP, Clements JA, Butler LM, Horsfall DJ, Tilley WD and Ricciardelli C (2010).
  2. Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer
    British Journal of Cancer (2012)106, 638-645
    King MT, Viney R, Smith DP,Hossain I, Street D, Savage E, Fowler S, Berry MP, Stockler M, Cozzi P, Stricker P, Ward J, Armb BK
  3. The impact of nerve sparing on incidence and location of positive surgical margins in radical prostatectomy
    BJU Int. 2012 Feb; 109(4): 533-8
    Moore BM, Savdie R, Pebenito RA, Haynes AM, Matthews J, Delprado W, Rasiah KK, Stricker P
  4. Superior quality of life and improved surgical margins are achievable with robotic radical prostatectomy after a long learning curve: a prospective single-surgeon study of 1552 consecutive cases
    Eur Urol. 2014 Mar;65(3):521-31
    Thompson J, Egger S, Bohn M, Haynes A-M, Matthews J, Rasiah K, Stricker P
  5. The Diagnostic Performance of Multiparametric Magnetic Resonance Imaging to Detect Significant Prostate Cancer
    2016 May;195(5):1428-35
    Thompson JE , van Leeuwen PJ , Moses D , Shnier R , Brenner P , Delprado W , Pulbrook M , Bohm M , Haynes A, Hayen A, Stricker P
  6. Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy
    BJU Int. 2016 Jan;117(1):48-54
    Tran M, Thompson J, Böhm M, Pulbrook M, Moses D, Shnier R, Brenner P, Delprado W, Haynes AM, Savdie R, Stricker P
  7. Prospective Comparison of the detection rate of 18F-Fluoromethylcholine and 68Ga-PSMA-HBED PET/CT in men with prostate cancer with rising PSA post curative treatment, being considered for targeted therapy
    J Nucl Med. 2015 Aug;56(8):1185-90
    Morigi J J, Stricker S, van Leeuwen P, Tang R, Ho B, Nguyen Q, Hruby G, Fogarty G, Jagavkar R, Kneebone A, Hickey A, Fanti S, Tarlinton L and Louise Emmett L
  8. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer
    BJU Int. 2017 Feb;119(2):209-215
    van Leeuwen PJ, Emmett L, Ho B, Delprado W, Ting F, Nguyen Q, Stricker P
  9. Superior Biochemical Recurrence and Long-term Quality-of-life Outcomes Are Achievable with Robotic Radical Prostatectomy After a Long Learning Curve—Updated Analysis of a Prospective Single-surgeon Cohort of 2206 Consecutive Cases
    Eur Urol. 2018 May;73(5):664-671.
    James E. Thompson'Correspondence information about the author James E. ThompsonEmail the author James E. Thompson, Sam Egger, Maret Böhm, Amila R. Siriwardana, Anne-Maree Haynes, Jayne Matthews, Matthijs J. Scheltema, Phillip D. Stricker
  10. Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy
    World J Urol. 2018 Mar 28.
    Matthijs J. Scheltema, John I. Chang, Maret Böhm, Willemien van den Bos, Alexandar Blazevsk, Ilan Gielchinsky, Anton M. F. Kalsbeek, Pim J. van Leeuwen, Tuan V. Nguyen, Theo M. de Reijke, Amila R. Siriwardana, James E. Thompson, Jean J. de la Rosette, Phillip D. Stricker
  11. A Multiparametric Magnetic Resonance Imaging Based Risk Model to Determine the Risk of Significant Prostate Cancer prior to biopsy
    BJU Int. 2017 Dec;120(6):774-781.
    Pim J. van Leeuwen, Andrew Hayen, James E. Thompson, Daniel Moses, Ron Shnier, Maret Böhm, Magdaline Abuodha, Anne‐Maree Haynes, Francis Ting, Jelle Barentsz, Monique Roobol, Justin Vass, Krishan Rasiah, Warick Delprado, Phillip D Stricker
  12.  Treatment outcomes from 68 GaPSMA PET CT informed salvage radiation treatment in men with rising PSA following radical prostatectomy: Prognostic value of a negative PSMA PET
    J Nucl Med. 2017 Dec;58(12):1972-1976.
    Louise Emmett1, Pim J. van Leeuwen, Rohan Nandurkar, Matthijs J. Scheltema, Thomas Cusick, George Hruby, Andrew Kneebone, Thomas Eade, Gerald Fogarty, Raj Jagavkar, Quoc Nguyen, Bao Ho, Anthony M. Joshua and Phillip Stricker
  13. Imaging: MRI improves cost and accuracy of prostate cancer biopsy
    Nat Rev Urol. 2018 Jan;15(1):6-8.
    James Thompson & Phillip Stricker
  14. Focal irreversible electroporation as primary treatment for localized prostate cancer
    BJU Int, 121: 716-24.
    van den Bos,W., Scheltema, M. J., Siriwardana, A. R., Kalsbeek A. M. F., Thompson, J. E., Ting, F., Böhm, M., Haynes, A. M., Shnier, R., Delprado, W., Stricker, P. D.
  15. Whole Genome Sequencing Reveals Elevated Tumor Mutational Burden and Initiating Driver Mutations in African Men with Treatment-Naive High-Risk Prostate Cancer.
    Cancer Res, Published Online September 14, 2018.
    Jaratlerdsiri, W., Chan, E. K. F., Gong, T., Petersen, D.C., Kalsbeek, A. M. F., Venter, P. A., Stricker, P. D., Bornman, M. S. R., Hayes, V. M.
  16. 3-year freedom from progression following (68)GaPSMA PET CT triaged management in men with biochemical recurrence post radical prostatectomy. Results of a  prospective multi-center trial.
    J Nucl Med. 2019
    Emmett, L., R. Tang, R. H. Nandurkar, G. Hruby, P. J. Roach, J. A. Watts, T. Cusick, A. Kneebone, B. Ho, L. Chan, P. van Leeuwen, M. Scheltema, A. Nguyen, C. Yin, A. Scott, C. Tang, M. McCarthy, K. Fullard, M. Roberts, R. Francis and P. Stricker
  17. p53 nuclear accumulation as an early indicator of lethal prostate cancer
    Br J Cancer 2019. 121 (7): 578 -583
    Quinn, D. I., P. D. Stricker, J. G. Kench, J. Grogan, A. M. Haynes, S. M. Henshall, J. J. Grygiel, W. Delprado, J. J. Turner, L. G. Horvath and K. L. Mahon.
  18. Metagenomic analysis reveals a rich bacterial content in high- risk prostate tumors from African men.
    Prostate. 2019. 79 (15): 1731 – 1738
    Feng, Y., W. Jaratlerdsiri, S. M. Patrick, R. J. Lyons, A. M. Haynes, C. C. Collins, P. D. Stricker, M. S. R. Bornman and V. M. Hayes
  19. The MRI in Active Surveillance (MRIAS); Trial: Use of Baseline mpMRI and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies.
    Journal of Urology. 2020.
    Amin, A., M. J. Scheltema, R. Shnier, A. Blazevski, D. Moses, T. Cusick, A. Siriwardena, B. Yuen, P. J. v. Leeuwen, A. M. Haynes, J. Matthews, P. Brenner, G. O'Neill, C. Yuen, W. Delprado, P. Stricker and J. Thompson

Please see the complete list of publications here

Top 5 Recent Invited Conference Presentations

  1. Stricker PD. The role of focal therapy in localized prostate cancer, preliminary Australian results. Invited speaker. American Urological Association Annual Meeting 15-19 May 2015, New Orleans, Louisiana, USA
  2. Stricker PD. MRI nomogram for prostate cancer. Invited speaker. 16 th Asia-Pacific Prostate Cancer Conference. Cairns Australia
  3. Stricker PD. Nanoknife focal therapy. Invited speaker. 3 rd Friends of Israel Urological Symposium 5-7 th July 2016. Tel-Aviv, Israel.
  4. Siriwardana A, Thompson J, Doig S, Kalsbeek A, Emmett L, Delprado W, Wong D, Samaratunga H, Haynes A, Couglin G and Stricker PD. Robot-assisted Salvage Node Dissection For Oligometastatic Nodal Disease Detected By 68Gallium-PSMA PET/CT: A Multicentre Retrospective Series. USANZ 2017 Annual Scientific Meeting 24-27 th February 2017, Canberra, Australia 2017 Keith Kirkland Prize Awarded
  5. Stricker PD. My learning curve and improving patient’s erectile function recovery. Invited speaker. Sydney Robotic Summit: Research and Innovation. 24 th June 2017 Sydney Australia.

Clinical Training

1979 – 1981
Junior Residency - St George Hospital

1982 – 1985
General Surgical Training and Fellowship

1986 – 1988
Urological Training and Fellowship

Visiting Urologist to St Vincent's Hospital, Sydney
Visiting Urologist to St Vincent's Private Hospital, Sydney
Visiting Urologist to St Luke's Hospital, Sydney

1989 - 2001
Visiting Urologist to the Royal Hospital for Women, Sydney

Consultant Transplant Surgeon to St George Hospital, Sydney

Conjoint Senior Lecturer University of NSW, Sydney

Conjoint Associate Professor University of NSW, Sydney

Clinical Associate Professor Sydney Medical School, Sydney University

Clinical Professor, School of Health Sciences, University of Tasmania

Conjoint Professor, School of Medicine, University of Western


Urological Society of Australasia

American Urological Association

European Urological Society

Prostate Cancer Foundation of Australia

Society International d'Urologie

Royal Australian College of Surgeons

NSW Urology Oncology Group

Positions Previously Held

Head, Prostate Cancer Group, Garvan Institute of Medical Research/St Vincent’s Hospital Campus

1998-2012 - Inaugural Director of the Prostate Cancer Foundation of Australia

Previous Major Grants Held

NHMRC Enabling Grant (ID No. 614296). "Australian Prostate Cancer Collaboration (APCC) Bio-Resource”. Clements J, Sutherland RL, Tilley W, Risbridger G, Marshall V, Roder D, Stahl J, Gardiner F, Nicol D, Frydenberg M, Pedersen J, Stricker P


Cancer Institute NSW Program Grant for Excellence in Translational Research. Personalised medicine for cancer: molecular biomarkers in clinical decision making for breast, prostate and pancreatic cancer. CIs: Horvath LG , Kench J, Boyer M, Millar E, O’Toole S, Beith J, Grimison P. AI: Stricker P. (10/TPG/1-04)

$3.75 million

Federal Government Grant – “The Chronic Disease Prevention and Service Improvement”. Australian Prostate Cancer Research Centre NSW. Mattick J, Spigelman A, Stricker P, Hayes V, Horvath L


Professional Experience

Open Radical Prostatectomy

Performed > 4500 cases.

Specialist in nerve sparing technique.

Mentored and trained Registrars, Fellows and Urological colleagues in nerve sparing technique.

Achieved international standard outcomes with <10% positive margins, up to 92% potency recovery and <2% long-term incontinence. These results have been presented and published in state, national and international meetings and journals.

Robotic Radical Prostatectomy

Commenced first robotic program in NSW at St Vincent's Private Hospital in February 2006 and currently has one of the largest series in Australasia.

Performed > 2200 cases (2006 – 2018).

Fully trained robotic Surgeon - particular expertise in nerve sparing robotic surgery.

Performed the first Dr Vip Patel nerve sparing technique radical prostatectomy in NSW.

Invited presenter on Robotic Prostatectomy at the World Robotic Symposium in Ohio 2007 and in Orlando in 2008 and 2010, Weill Cornell Medical College New York 2011 , FOI Urology Conference  Israel 2012 & 2016 , Urology Society of Australia and New Zealand ASM  2010 , 2014 , APCC – Robotic Masterclass 2011 , Asia Pacific PCC – Robotic Masterclass 2013 , Sydney Robotic Symposium – Preservation of potency in Robotic RP 2017

Excellent results with low positive margin rate ( <1% pT2 ), high continence (98%)  and good potency results ( > 70% overall ).

Mentor to other surgical units (Asiapacific , Western Australia, Queensland & New Zealand).

Reviewer  of  submitted articles to The Journal Urology , Lancet , European Urology , Journal of Robotic Surgery , BJUI , Lancet oncology ,

Manages the Robotic Fellowship Program at St Vincent's Private Hospital.

Published personal series in The Journal “European Urology” 2014 & 2017

Low Dose Rate Brachytherapy (Seeds)

Personal series of > 1000 cases (1997-2017). One of the largest series in Australasia.

Introduced Seeds to Eastern Australia in 1996

Results have been presented and published at national and international meetings.

Mentored and trained many of the units in Australia.

In 2001, with the support of the Urological Society of Australia arranged the acceptance of Brachytherapy as an approved item number by Medicare in the therapy for prostate cancer.

High Dose Rate Brachytherapy:

Largest personal series in Australia and one of the largest series in the world, with >1000 cases performed personally (1998-2017).

Presented and published at national and international meetings.

Mentored and trained multiple Urologists in the technique.

Began the first program in 1998 in Australia with Mark Stevens

Focal Therapy (HIFU & Nanoknife IRE) for localised PC

Commenced HIFU in October 2005 – the first unit in Australia.

2013 commenced Nanoknife (IRE) as a focal therapy.

One of four international academic sites evaluating Nanoknife (IRE) focal therapy.

Performed 180 cases of Focal IRE 2013-2017

Active Surveillance

>1000 cases on active surveillance since 1999.

The largest series in Australia.

Structured program of follow-up with PSA, transperineal biopsies of the prostate and MRI scans.

Chief Investigator in evaluation of mMRI in Monitoring Active Surveillence

Sexual Health Rehabilitation

Enormous experience in sexual rehabilitation and preservation and one of the acknowledged experts in Australia.

Set up one of the largest multidisciplinary sexual dysfunction clinics in the Southern Hemisphere (the Australian Centre for Sexual Health 1991-2001).

Trained Dr Michael Lowy who now has particular expertise in this area.

Investigator in the original research on Viagra on the protection of potency after radical prostatectomy surgery, being one of the highest accrual centres in the world and the largest in Australia.

Currently still involved in multiple projects pertaining to sexual rehabilitation after surgery.

Incontinence Therapy after Prostate Cancer Treatment

  • Personal series of >150 cases of insertion of artificial urinary sphincter for severe urinary incontinence. His experience includes the more complex artificial sphincter cases such as the use of double cuffs, complex revisions, transcorporal implantation and complex erosions. He was trained by Professor Richard Millard and Professor Robert Farnsworth.
  • Post radical prostatectomy incontinence – Professor Stricker has been treating post radical prostatectomy incontinence for 30 years. He has developed a tertiary referral practice from many urologists including Dr Carlo Yuen, Dr Phillip Brenner, Dr Haxhimolla, Dr Jefferson and previously David Golovsky. Trained by Prof Millard, S Raz, Rodney Appell, Ed Mcguire and Dean Knoll.
  • Large experience in the use of the ProAct Device (50-100 cases) and Collagen Implant in the treatment of minor urinary incontinence.
  • Works in close association with a dedicated pelvic floor Physiotherapist Stuart Baptist in managing incontinence and post RP recovery.
  • Urodynamics – Professor Stricker has personally performed a large volume of urodynamic procedures since 1988 for approximately 15 years. He was taught by Professor Richard Millard. The technique he used was video urodynamic assessment. When his practice became too busy to perform the urodynamic assessments, he continued to assess incontinent patients and referred the patients for urodynamic assessment to Professor Millard and after his retirement to Vincent Tse and then Lewis Chan.
  • Sling procedures – Extensive and long experience in InVance and AdVance slings including the more recent AdVance XP sling, having performed these regularly for almost 20 years. He was trained by the initiator of the transobturator sling Dr Dean Knoll and further formal training in Paris in 2008. In addition, he has been a teacher to many urologists and trainees in sling surgery including Dr David Jefferson, Richard Savdie, Carlo Yuen, Kris Rasiah, Anthony Hutton, Phil Brenner and Peter Chin as well as his fellows and registrars.

Second Opinion Service

Over 20 years of experience in tailoring treatment to patient's needs.

Initiated a large multidisciplinary team for appropriate support throughout all treatments.

Offers second opinion on website:

Transperineal Grid-directed Prostate Biopsy Technique

Developed and first described this technique internationally in 1997.

Over 7,000 cases performed

Has minimised the chance of post biopsy sepsis using this technique.

Has presented and published on this technique nationally and internationally.

Has mentored and trained Urologists, Fellows and Registrars in this technique.

Invited chapter in Hinman’s Atlas of Urology 4 th edition

Magnetic Resonance Imaging and Spectroscopy (MRI/MRS):

First looked at the accuracy of this technology in prostate in 2007. In 2012 initiated several studies at St Vincent’s Campus evaluating MRI accuracy in comparison to prostate biopsies, PCA3 and prostate health index (PHI). Initial results from the study were presented at the AUA, European and Australian meetings.

International and national teacher of the role of MRI in prostate cancer.

Over 10 international publications (see CV Summary).

PSMA PET  Scanning:

Initiated the first unit in NSW.

Published multiple prospective studies on the accuracy of this technology.

International & national speaker on PSMA

Books, Chapters and DVDs

1995 Tumour Markers and Flow Cytometry. Chapter in book "The Bladder". Fitzpatrick and Krane. Chapter by P.Stricker and P.Russell. Pg 385-394.

2000 July. The Australian Medical Association. "Home Medical Guide to Prostate Disorders". Consulting Editor.

2003. "Treatment of Localised Prostate Cancer". Member of the Prostate Cancer Working for Cancer Network Australia.

2004 "PSA for the General Practitioner" Book. P.Stricker and K. Phelps.

2008 "Prostate Cancer for the General Practitioner." Book P. Stricker and K.Phelps.

2008 "So I Have Prostate Cancer, What Now?" PCFA DVD

2009 "How Do You Choose" DVD. P Stricker

2010 "Intergrative Medicine for the General Practitioner" Book. Hassad and Phelps.

Chapter on prostate cancer.

2012 Series of DVD’s – P Stricker. “Pelvic Floor Exercises, Moving Forward”,

“Prevention & Localised Prostate Cancer”, “Advanced Prostate Cancer & Hormone

Treatments”, Cured of Prostate Cancer – What About Quality of Life”, “Return to

Potency after Prostate Cancer”, Prostate Cancer Treatments-Managing Side

Effects”, Prostate Cancer – Integrative Medicine Taking Control”, Prostate Cancer

– Urinary Control”, Advanced Prostate Cancer – Prof. Charles Myers, Prostate

Cancer - managing the Mind”, “Robotic Surgery – The Journey”.

2013 “Improving outcomes in robotic radical prostatectomy.” Chapter 7. Editor Vip Patel.

2014-15 “Clinical Practice Guidelines for PSA Testing & Early Management of Test-Detected Prostate Cancer” Prostate Cancer Foundation of Australia & Cancer Council Australia. NHMRC approved. Part of the expert advisory panel.

2018 “Early detection and screening for prostate cancer.” 2nd Edition. Dahm and Dmochowski. ch. “Evidence-Based Urology”, pp. 257-265. P. van Leeuwen, M.J. Roobol and P.D. Stricker

Symposia Convened - National and International

Impotence Symposium of Australasia - Operative Workshop St Vincent's Hospital - 1991. Editor of Monograph. Presentations on "Intracorporeal Pharmacotherapy - Results and Complications" - P. Stricker (T.Dean) & "Polypharmacotherapy" – P.Stricker (L.Jacobs) Convenor

Update of Urology for GP's University of NSW 1993. Presentations on Renal calculi, Prostate cancer & Impotence Convenor

Society Internationale d'Urologie 23rd Congress Meeting Sydney. 1994. Editor of daily proceedings & Presenter

Prostate Cancer Symposium - Operative Workshop St Vincent's Clinic 1995. Editor of Monograph. Presentation on "Radical Perineal Prostatectomy - St Vincent's Experience". Convenor

Impotence Management Symposia. P Stricker - Chairman of Australian Impotence Advisory Board 1995

Australian Society of Impotence Medicine Inaugural Meeting 1997. 4 Presentations & Surgical Workshop Co Convenor

Inaugural National GUOG Meeting (Leura). Presentations & Workshop on Prostate Cancer Surgery Co Convenor

Brachytherapy for Prostate Cancer Symposium with J.Blasko St Vincent's Hospital. 1997 Convenor and Demonstrated

Prostate Cancer Symposium - Presentation on Radical Prostatectomy Garvan Institute. 1999 Convenor

Benign Prostatic Hypertrophy - Laser Prostatectomy St Vincent's Hospital. 1999 Co Convenor

Prostate Cancer Update with Peter Scardino - Operative Workshop St Vincent's Hospital. 2001 Convenor

Laparoscopic Radical Prostatectomy - Operative Workshop St Vincent's Hospital. 2003 Convenor R.Kooner & P.Stricker

Brachytherapy Workshop with Michael Zelefsky - Operative Workshop St Vincent's Hospital 2005. Convenor

Robot Assisted Radical Prostatectomy with Vip Patel - Operative Workshop St Vincent's Hospital 2007. Convenor.

MRI of the Prostate – A Multidisciplinary Symposium – May 2012. Co-convenor.

Focal Therapy, Imaging & Biopsy Techniques with Mark Emberton Operative Workshop St Vincent’s Hospital, 2013. Convenor.

Recent Key National and International Presentations

Beattie K and Stricker P. Prevalance of high risk features in radical prostatectomy specimens in patients who met criteria for nerve-sparing radical prostatectomy. Oral presentation at the Urological Society of Australia and New Zealand (USANZ) NSW section meeting. 9-12 Nov 2013, Hamilton Island, Australia

Thompson J and Stricker P. Comparison between the accuracy of 12, 16 and 20 core TRUS biopsy in detecting significant prostate cancer and correlation with grade and location on radical prostatectomy. Oral presentation at the Urological Society of Australia and New Zealand (USANZ) NSW section meeting. 9-12 Nov 2013, Hamilton Island, Australia

Thompson J and Stricker P. Superior Quality of Life and Improved Surgical Margins Are Achievable with Robotic Radical Prostatectomy After a Long Learning Curve: A Prospective Single-surgeon Study of 1552 Consecutive Cases. Oral presentation at the Urological Society of Australia and New Zealand (USANZ) NSW section meeting. 9-12 Nov 2013, Hamilton Island, Australia

Tran M, Jackson B, Boehm M, Haynes A-M, Stricker P, Irreversible Electroporation for Focal Prostate Cancer: Safety, Short-term Functional and Oncological Outcomes. Poster Presentation . 68 th Urological Society of Australia and New Zealand Annual Scientific Meeting 11 th – 19 th April 2015, Adelaide, South Australia

Tiwari A, Haynes A-M, Nguyen Q, Hammond G, Kench JG, Horvath LG, Stricker PD. A Prostate Cancer Biorepository meeting International Collaborative Demands. Poster Presentation. International Society for Biological and Environmental Repositories (ISBER) 2015 Annual Meeting and Exhibits 5-9 May 2015, Phoenix Arizona, USA

Tiwari S, Haynes A-M, Nguyen Q, Hammond G, Kench JG, Horvath LG, Stricker PD. The Garvan Query Application (GQA): A Comprehensive Search Engine for a Prostate Cancer Biorepository. Poster Presentation. International Society for Biological and Environmental Repositories (ISBER) 2015 Annual Meeting and Exhibits 5- 9 May 2015, Phoenix Arizona, USA

Thompson J, Shnier R, Moses D, Brenner P, Delprado W, Tran M, Ponsky L, Boehm M, Haynes A, Stricker P. Oral Presentation. Prospective study of pre-biopsy multiparametric magnetic resonance imaging (mpMRI) compared to transperineal template mapping biopsy (TTMB) for detection of clinically significant prostate cancer: is it accurate enough to guide selection of men for biopsy? Oral Presentation. American Urological Association Annual Meeting 15-19 May 2015, New Orleans, Louisiana, USA

Tran M, Thompson J, Boehm M, Pulbrook M, Moses D, Shnier R, Brenner P, Delprado W, Haynes A-M, Savdie R, Stricker P. Combination of multi-parametric magnetic resonance imaging (mp-MRI) and transperineal template-guided mapping biopsy (TTMB) of the prostate to identify candidates for hemi-ablative focal therapy. Poster Presentation. American Urological Association Annual Meeting 15-19 May 2015, New Orleans, Louisiana, USA

Algohary A, Viswanath S, Prasanna P, Pahwa S, Gulani V, Moses D, Shnier R, Böhm M, Haynes A-M, Brenner P, Delprado W, Thompson J, Pulbrock M, Stricker P, Ponsky L, Madabhushi A. Quantitative assessment of T2-weighted MRI to better identify patients with prostate cancer in a screening population. Poster Presentation. American Urological Association Annual Meeting 15-19 May 2015, New Orleans, Louisiana, USA

Nguyen Q, Haynes AM, Horvath L and Stricker PD. Prostate Cancer Research: From Lab Bench to Beside: A prospective from the Trenches. Poster presentation. 9 th Health Services and Policy Research Conference 7 – 9 th Dec 2015. Melbourne, Australia

Siriwardana A, van Leeuwen PJ, Roobol M, Ting F, Nieboer D, Thompson J, Delprado W, Haynes A, Brenner P, and Stricker P. Predicting low-risk prostate cancer from transperineal saturation biopsies. American Urological Association Annual Meeting 2016 – 6-10th May, 2016. San Diego,USA.

Siriwardana A, Thompson J, Hayen A, Ting F, Delprado W, Brenner P, Ende D, Kooner R, O’Neill G, Yuen C, Tiwari S, Haynes A and Stricker P. Lymph node yield at radical prostatectomy is a predictor of biochemical recurrence-free survival (BFS) in high-risk prostate cancer patients. USANZ 2017 Annual Scientific Meeting 24-27th February 2017, Canberra, Australia

Thompson JE, Egger S, Bohm M, Siriwardana A, Haynes AM, Matthews J, Scheltema M, Stricker PD. Superior biochemical recurrence and quality of life outcomes are achievable with robotic radical prostatectomy versus open radical prostatectomy – update of a prospective single-surgeon study of 2206 consecutive cases. 5th Global Congress on Prostate Cancer. 28 – 30 June 2017, Lisbon Portugal

Scheltema, MJ, van den Bos W, Siriwardana AR, Kalsbeek AMF. Thompson JE, Ting F, Bohm M, Haynes AM, Shnier R, Delprado W, Stricker PD. Focal Irreversible Electroporation as primary and salvage treatment for prostate cancer. 5th Global Congress on Prostate Cancer. 28 – 30 June 2017, Lisbon Portugal

Scheltema MJ, Chang JI, van den Bos, Bohm M, Delprado W, Gielchinsky I, de Reijke TM, de la Rosette J, Sirawardana AR, Shnier R, Stricker PD. Diagnostic Accuracy of Mulitparametric Resonance Imaging Following Prostate Cancer Focal Therapy with Irreversible Electroporation. 93rd Annual Meeting Western Section of the American Urological Association, 6 -10 August 2017, Vancouver British Columbia Canada

Scheltema MJ, Chang JI, Bohm B, van den Bos W, Gielchinsky I, Kalsbeek AF, van Leeuwen PJ, de Reijke TM, Siriwardana AR, de la Rosette JJ. Stricker PD. Pair-matched Patient-reported Quality of Life following Focal Irreversible Electroporation versus Robot- assisted Radical Prostatectomy. 37th Congress of the Societe Internationale d’Urologie. 19-22 October 2017, Lisbon Portugal.

Blazevski A, Pidsley R, Qu W, Norbie D, Luu L, Chang J, Yuen B, Scheltema MJ, Masand N, Haynes AM, Nguyen Q, Stirzaker C, Song J, Stricker P, Clark S. When Focal Therapy Fails for Localised Prostate Cancer – Can Epigenetics Predict Which Patients Fail and Improve Patient Selection? ANZUP ASM 8 – 10 July 2018. Sydney, Australia.

Blazevski A, Yuen B, Scheltema MJ, Masand N, Haynes AM, Nguyen Q, Stricker P. Oncological Outcomes of Focal Irreversible Electroporation as Primary Treatment for Clinically Significant Localised Prostate Cancer. 38th Congress of the Société Internationale d’Urologie. 4 – 7 October 2018. Seoul, Korea

Blazevski A, Scheltema MJ, Yuen B, Masand N, Haynes AM, Cusick T, Shnier R, Stricker P. Diagnostic accuracy of multiparametric magnetic resonance imaging to detect residual prostate cancer following focal therapy with irreversible electroporation. EAU 2019 – Annual Scientific Meeting – Barcelona.

Amin A, Blazevski A, Scheltema MJ, Stricker P, Thompson J. The MRI in active surveillance study (MRIAS): A prospective single arm cohort study replacing confirmatory biopsy with mpMRI in active surveillance for low risk prostate cancer - Asia-Pacific Prostate Cancer Conference 2019 - Melbourne, Australia.

Amin A, Blazevski A, Scheltema MJ, Thompson J, Stricker P. Salvage Radical Prostatectomy After Focal Irreversible Electroporation for Prostate Cancer: A Case Series Reporting Oncological Outcomes. Société International d’Urologie 2019 – Athens.

International and National Invited Surgeon

Malaysian Urological Society

Korean Urological Society


Chinese Urological Society


Western Australian Urological Society – Robot Assisted Radical Prostatectomy


Queensland Australian Urological Society – Robot Assisted Radical Prostatectomy

Invited Presentations


Australasian Urological Society Annual Meeting - Intravesical BCG. "Immunotherapy & Chemotherapy - 10 year experience"


Australasian Ultrasound Society - Annual Meeting

1.Transrectal ultrasound for prostate.

2. Penile Duplex ultrasound.

New Zealand Urological Society -"Transurethral needle ablation of the prostate". P.Stricker, G. Coombes.

Malaysian Urological Society – Incontinence & Collagen Implant


International Urological Society - 23rd Congress

1. B.C.G. for Bladder cancer

2.Collagen for Stress Incontinence

3.TUNA for B.P.H.

8th Congress of World Ostomy Association – Adelaide."Sexual consequence of Surgery".


Queensland Assert & Sexual Health Society Meeting. Specialised investigation of Impotence.

International Menopause Society

Symposium of male Sexual Dysfunction.

8th African Urological Society. Invited speaker "Peyronie's and side effects of injection treatment"


South Australian Urological Society Meeting. Presentations on:

1.Role of Surgery for prostate cancer

2.Peyronie's Disease

3.Collagen Implant for Male Incontinence

South Africa Visiting Lecturer -"Peyronie's Disease & Injection Therapy"


Annual Urological Society of Australia Meeting – Adelaide. "Peyronie's Disease"


Shanghai Urological Group - Shanghai China."1125 Brachytherapy for Prostate Cancer"

Asia-Pacific Urological Association Annual Meeting - Beijing China

- Brachytherapy for Prostate Cancer

- Prostate Cancer and Sexual Dysfunction


Victorian State Urology Meeting. Presentations on:

- Brachytherapy

- Prostate Cancer

- Peyronie's Disease

- Grid Biopsy

Urological Society of Australasia (USA) - Annual Scientific Meeting

"Medico Legal Aspect of Prostate Cancer"

Australian Prostate Cancer Collaboration (APCC) ASM.

"Nomogram Validation for Prostate Cancer"


Annual Australian Urological Meeting. Presentation on Prostate Cancer

NSW Urology Meeting. Presentation on Prostate Cancer.

National Prostate Cancer Symposium. Presentation on Prostate Cancer


American Urological Association (AUA) Meeting - 2 presentations

Australian Annual Scientific Urology Meeting - 7 presentations

APCC - presentation on Prostate Cancer

Australian Brachytherapy Society -"Outcomes of High & Low Dose Brachytherapy"

Sloan Kettering Prostate Cancer Meeting - "Prostate Cancer Outcomes"

Eli Lilly Company Meeting -"Prostate Cancer & Erectile Dysfunction"

National Prostate Cancer Symposium -"Prostate Cancer & Surgery"


Australian Brachytherapy Society - 2 presentations

Urological Society of Australasia - 2 presentations

Uro-Oncology Group of NSW - "Radical Prostatectomy"

Sydney University - Debate on Prostate Cancer

NSW Urology Meeting - 3 presentations

Australian-Israeli Chamber of Commerce - presentation on Prostate Cancer


Australasian Urological Society - 2 presentations

Chinese Urological Society - 2 presenations

St Vincent's Hospital "Steggles" Conference

Brachytherapy Symposium - 4 presentations

Asia Pacific Uro-Oncology Meeting - presentation on "HIFU"

World Health Organisation Symposium Paris -Presentation on Prostate Cancer.

NSW Urological Society Meeting - 2 presentations


Australasian Urological Society - 3 presentations

NSW Urological Society Meeting - 4 presentations

7th National Prostate Cancer Symposium Melbourne

Presentation on "HIFU"


Australasian Urological Society - 2 presentations

General Practitioners Continuing Education Annual Meeting - 3 presentations

Urology Oncology Group Meeting - 2 presentations

2nd International Robotic Symposium Ohio - 1 presentation

PCFA Men's Health Promotion Forum – Prostate cancer treatment panel – radical prostatectomy (open, robotic & laparoscopic).

NSW Nurses Urological Society meeting – Topic: Prostate Cancer. October


3rd International Robotic Symposium Orlando - 2 presentations. March

Laverty Pathology Men's Health Conference for GPs - Topic: Prostate Cancer.

Nurses Surgical Symposium Westmead Hospital – “Prostatectomy & Robotic Surgery”.

General Practitioner's Continuing Education Annual Meeting – Prostate cancer & PSA.

Prostate Cancer Foundation of Australia Hunter Region

Western Australian Urological Society National Annual Scientific Meeting -3 presentations.

Prostate Cancer Foundation of Australia 1st National Conference, Gold Coast "Future of Prostate Cancer".


18th Australasian Brachytherapy Group Annual Scientific Meeting, Gold Coast -1 presentation.

Australasian Urological Annual Meeting. Gold Coast - 3 presentations


Australasian Urological Society Annual Meeting Perth -2 presentations and debate: "Robotic Assisted Laparoscopic Radical Prostatectomy is the Gold Standard Surgical Treatment for Prostate Cancer".

5 th International Robotic Symposium Orlando. “Continence after robot radical prostatectomy”.

Integrative Medicine Society Meeting. “Integrative prostate cancer treatment” & “Robotics in prostate cancer surgery.”

11 th National Prostate Cancer Symposium Melbourne. August. “Continece post robotic radical prostatectomy”.

New Zealand Urological Meeting. “Prostate Cancer - How to choose” & “Robotic surgery”.

PCFA National Conference. “Prostate Cancer – How to choose” & “Side effects management”.


NSW Section Urological Meeting, Sydney, November Point Counterpoint – Locally Advanced Prostate Cancer.

NSW Urological Nurses Conference, Sydney "How does one make a choice between different prostate cancer treatment modalities and robotic surgery".

12th Australasian Prostate Cancer Conference (APCC), Melbourne, August. Master class in robotic surgery.

Trainee Week 2011 "Localised Prostate Cancer – What We Do Know, What We Don’t". Factors in favour of robotic radical prostatectomy surgery.

General Practitioner Annual Symposium, Sydney, May.

1. Prostate cancer update

2. Benign prostatic hyperplasia update

The Inaugural international prostate cancer symposium – Weill Cornell Medical College New York.

1. Locally advanced prostate cancer

2. Benefits of robotic radical prostatectomy.

American Urological Society Annual Scientific Meeting. Washington, May.

1. Quality of Life

2. Transperineal biopsy of prostate

3. Locally advanced prostate cancer.


GlaxoSmithKline Australia Pty Ltd GP Dinner, March. "STEP UP – Do more for your patients with BPH".

Friends of Israel Urological Symposium Tel Aviv May.

1. Learning curve of robot assist prostatectomy.

2. Nerve sparing radical prostatectomy – How do I do it -Bladder neck dissection and dissection of seminal vesicles.

NSW State Parliament Sydney. “Prostate cancer update”.

MRI of the Prostate – A Multidisciplinary Symposium. May. Sydney

1. The role of MRI

2. Screening and MRI

The Australian Vietnamese Health Professionals Association NSW Inc. – Annual Scientific Conference. October. Sydney. PSA & Prostate Cancer Update.


3rd Congress of Asian Pacific Prostate Society (APSS) – 13 th April. Melbourne

“How to improve continence & potency after robot-assisted radical prostatectomy”.

St Vincent’s Campus Steggles Conference – April. Sydney

1. Focal therapy – Are we ready?

2. Biopsy techniques – TRUS v’s Transperineal

3. 2 live cases presentation (Nanoknife & HIFU)


USANZ 67 th Annual Scientific Meeting– The role of MRI in the early detection of prostate cancer

The role of MRI – Asia Pacific Imaging meeting

USANZ South Australian state section meeting – presentations on MRI & Focal therapy

USANZ NSW state section meeting – presentations on salvage radical prostatectomy, MRI, Nanoknife.

Tolmar lecture series – Focal therapy

Prostate cancer update – CME GP talk September


AUA New Orleans May

1. BAUS/BJUI/USANZ – The role of focal therapy in localized prostate cancer, preliminary Australian results

2. MRI presentations.

Cleveland Clinic & Case Western Reserve University Ohio – May

1. Transperineal biopsies

2. Focal therapy

3. MRI

RANZCR NSW Branch Education evening – An update of MRI in prostate cancer

NSW State Section Meeting – 7 th November 2 presentations

1. Focal therapy

2. Overview of prostate cancer imaging

Royal Australasian College of Surgeons NSW – 10 th November Graham Coupland Lecture – “The Challenge of Prostate Cancer Care – Past, Present & Future”


USANZ Annual Scientific Meeting. MRI Education Course –all day course, Focal Therapy Debate

Euroean Meeting EAU - 2 papers on PSMA PET SCanning

Asia-Pacific Prostate Cancer Annual Meeting. New MRI Nomogram for PC

Israel FOI International Meeting. Nanoknife Update, Surgery versus Radiation Debate , Robotic RP Technique

AUA. Focal Therapy - How to select

Webinar – Diet and Prostate Cancer


USANZ 2017 - Focal therapy nanoknife and PSMA Imaging and MRI Imaging workshop

Robotic Symposium - Potency preservation in Robotics

PROSCA Portugal - Focal Nanoknife, Robotic RP

Tasmania ASM - Prostate Cancer Update - 8 hours

MRI Fusion Workshop - Co Convenor


Hadassah Medical Center Jerusalem – Key note speaker for salvage prostate cancer treatment

Hadassah Hospital, Jerusalem – 3-week educational session and facility upgrading program. Work involved updating the robotic surgery program, Nanoknife program, MRI-fusion program, brachytherapy program, multidisciplinary team, PSMA program, transperineal biopsy program and establishment of a link between Hadassah and St Vincent’s Hospital for research

Australasian Student’s Surgical Conference – Robotic surgery

National Robotic Symposium – Centralisation of robotic services

National Cancer Institute – Introduction of NanoKnife to Amsterdam

Netherlands Cancer Institute, Amsterdam – Operation of the DETECT probe for prostate cancer

Global Congress on Prostate Cancer, Frankfurt, Germany – PSMA screening and NanoKnife treatment

Friends of Israel Urology Symposium – Robotic Surgery, PSMA Screening and Nanoknife

38th Congress of the Société Internationale d’Urologie, Seoul, Korea – Ideal framework for the introduction of Nanoknife – Presented on behalf of Professor Stricker by Urology Fellow Dr. Alexandar Blazevski 2019


34th Annual European Association of Urology Congress – Irreversible Electroporation (IRE) for Prostate Cancer – Presented on behalf of Professor Stricker by Urology Fellow Dr. Alexandar Blazevski

27th St Vincent’s Campus Research Symposium - Improving both oncologic and functional outcomes in prostate cancer via innovations in imaging, robotics and biomarkers – Presented on behalf of Professor Stricker by Dr. James Thompson

Professional Contributions

Chief investigator of numerous pre-clinical and clinical research projects at St Vincent's Campus.

In 1994 established the St Vincent's Prostate Cancer Clinical Database and Tissue Bank in conjunction with the Garvan Institute. These contain extensive clinical and pathological outcome data and have resulted in a comprehensive scientific and clinical source that has been acknowledged both nationally and internationally.

Instigated the establishment of the St Vincent's Hospital Prostate Cancer Group.

Education and mentoring of other Urologists and Urology Fellows in the area of prostate cancer treatments and procedures.

Prostate cancer grants for NHMRC - Reviewer

Cancer Council "Localised Prostate Cancer" book - Member of review committee for both editions.

"Your Guide to Prostate Cancer" by Dr Prem Rashid - Member of peer review group.

Member of the Australian Cancer Network working party that developed guidelines for the Management of Localised & Advanced Prostate Cancer. This has been published and was the first evidence based publication through the network.

This was supported by the NHMRC.

Regularly reviews manuscripts on prostatic conditions especially prostate cancer for peer reviewed journals including Medical Journal of Australia, Medicine Australia, Australian Prescriber,J.Urol, MJA, Eur Urology.

Research Supervisor for PhD/Masters students - Dr's David Quinn, Lisa Horvarth, Kris Rasiah, Ruban Thanigasalam, Kim Pryor, Andy Huo, James Symons, Richard Savdie and James Thompson.

Supervisor of the Urology Fellow program at St Vincent's campus.

Co-author with Prof. Kerryn Phelps of the first national "PSA for the General Practitioner" book. This book was distributed to all GP's in Australia in 2004. An updated edition was written in 2008.

Regular contributor to the "St Vincent's Clinic Proceedings" Magazine on new developments and treatments for prostatic conditions.

Advisor to the NSW Cancer Council (book reviews).

Member of PSA review board – PCFA & NHMRC.

Contribution to the British Journal of Urology International e-learning modules for prostate cancer

Public Contributions

Prostate Cancer Support Network

Along with Jayne Matthews was involved in the initiation of the first prostate cancer support group in Australia at St Vincent's Hospital, Sydney. Has also been instrumental in the development of the Association of Prostate Cancer Support Groups throughout Australia and incorporating this in the Prostate Cancer Foundation of Australia.

Invited guest speaker at many prostate cancer support groups in NSW and ACT.

Guest speaker at the Inaugural NSW Men's Health Promotion Conference organised by the Prostate Cancer Foundation of Australia.

Public Education Information Brochures

Active member in an educational sense on prostate cancer issues through frequent contributions to newsletters, tapes/DVD's and a series of books. "Lifebuoy" - St Vincent's Campus prostate cancer support group newsletter and "Prostate News" - The Prostate Cancer Foundation of Australia.

AMA prostate cancer guidelines.

DVD for prostate cancer information for support groups (PCFA & personal).

Cancer Council booklet on Prostate cancer.

Television, Radio and Newspaper Interviews/Articles

Invited guest speaker on several community programs to discuss new developments in prostate cancer such as:

-Television: 60 Minutes-Channel 9, "What's Good for You",“A Current Affair” and Prime Time News on all TV stations.

- Radio: 2GB, John Laws, Dr John D'Arcy and ABC Radio national

- Newspapers: Financial Review and the Sydney Morning Herald

Website Service

Developed the official website for the St Vincent's Prostate Cancer Centre, .

General Practitioner Education

"PSA for the General Practitioner" - Co author with Prof. Kerryn Phelps. This book was distributed to all G.P's throughout Australia.

GPCE (General Practitioner Continuing Education) Annual Conference - regular invited speaker at the National Conference for GP's held annually.

Invited guest speaker at numerous GP groups both in metropolitan and rural areas.

"Prostate Cancer for the General Practitioner" PSA Booklet Edition 2. Co-authored with Prof. Kerryn Phelps. This book was distributed to 21,500 GP's and Specialists throughout Australia (2008).

Prostate Cancer Foundation of Australia

Inaugural Director

Been integral in raising funds and establishing policy as a Foundation member of the organisation.

Contributed to the national "Be A Man" campaign to raise awareness of prostate cancer in the community.

Urology Nurses Education

Along with the nurses at St Vincent's Private Hospital, has constructed a diploma course in Urology, particularly in prostate cancer. This diploma course is now conducted annually.

Invited guest speaker at several NSW & Australian Urology Nurses Society conferences on prostate cancer treatments.

Research Fellows Supervised

Michael Hoch (France)

Petr Macek (Czech Republic)

Ziv Maianski (Israel)

Ruban Thanigasalam

Can Huynh

Paul Chen

Carlo Yuen

Richard Savdie

Nicolas Doumerc (France)

James Symons 2012

Tania Hossack 2012

James Thompson 2012

Lee Ponsky (USA) 2013

Minh Tran 2014

Pim Van Leeuwen (The Netherlands) 2015

Francis Ting 2015

James Thompson PhD 2017

Anton Kalsbeek PhD 2017

Amila Siriwadarna Masters 2017

Matthijs Scheltema PhD 2017

Wilhemien Van Den Bos PhD 2017

Anton Kalsbeek PhD 2015 – 2017

Ilan Gielchinsky Robotic 2017

John Chang, Masters 2017

Alex Blazevski 2018

Brian Yuen 2018

Amer Amin 2019

William Gondoputro 2020

Registrars Trained

Stuart Ehsman

Peter Nash

Graham Coombes

Justin Vass

Paul Kovac

Paul Gassner

Ramin Samali

Michael Wines

Hodo Hoximollo

Jim Adshead

Venu Chalasani

Charles Chabert

Can Huynh

Claire Whelan

Anthony Hutton

Key aspects

From diagnosis and treatment to rehabilitation and research, I believe my highly experienced team and I bring a multifaceted approach to understanding and helping our patients. A summary of these key aspects of that approach is available here in PDF format. If you are suffering from prostate cancer or have reason to believe you might be, you are welcome to contact us or, intially, complete our comprehensive second opinion form.